Targeting the NRF2 pathway: A promising approach for corneal endothelial dysfunction

Area of Science:

• Ophthalmology and Vision Science
• Cellular Biology
• Molecular Medicine

Background:

• Corneal endothelial dysfunction is a leading cause of vision loss globally.
• Current therapeutic innovations for corneal endothelium are limited.
• Oxidative stress and mitochondrial dysfunction play key roles in corneal endothelial diseases.

Purpose of the Study:

• To review the role of the NRF2 pathway in maintaining corneal endothelial health.
• To explore NRF2's potential in treating corneal endothelial dysfunction.
• To focus on Fuchs' endothelial corneal dystrophy and post-cataract surgery complications.

Main Methods:

• Literature review of recent scientific developments.
• Analysis of the NRF2 pathway's function in corneal endothelial cells.
• Examination of NRF2's impact on oxidative stress and mitochondrial function.

Main Results:

• The NRF2 pathway is crucial for corneal endothelial health.
• NRF2 activation promotes antioxidant and mitochondrial functions.
• NRF2 plays a significant role in Fuchs' endothelial corneal dystrophy and cell loss post-surgery.

Conclusions:

• NRF2 activation presents a promising therapeutic strategy for corneal endothelial diseases.
• Targeting the NRF2 pathway offers a novel approach to preserving vision.
• Further research into NRF2-based therapies is warranted for corneal endothelial dysfunction.